RD Gelber

3.6k total citations · 2 hit papers
37 papers, 2.7k citations indexed

About

RD Gelber is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, RD Gelber has authored 37 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 21 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in RD Gelber's work include Breast Cancer Treatment Studies (21 papers), HER2/EGFR in Cancer Research (14 papers) and Advanced Breast Cancer Therapies (13 papers). RD Gelber is often cited by papers focused on Breast Cancer Treatment Studies (21 papers), HER2/EGFR in Cancer Research (14 papers) and Advanced Breast Cancer Therapies (13 papers). RD Gelber collaborates with scholars based in Switzerland, Italy and United States. RD Gelber's co-authors include J R Anderson, Kevin C. Cain, Aron Goldhirsch, Carl‐Magnus Rudenstam, Rastko Golouh, Jennifer Styles, Richard Reed, B.A. Gusterson, Rajakumar Anbazhagan and Karen N. Price and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

RD Gelber

33 papers receiving 2.7k citations

Hit Papers

Analysis of survival by tumor response. 1983 2026 1997 2011 1983 1992 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Analysis of survival by tumor response.
    1983 840 citations RD Gelber et al. Journal of Clinical Oncology profile →
  2. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
    1992 698 citations B.A. Gusterson, RD Gelber et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RD Gelber Switzerland 17 1.7k 909 502 485 465 37 2.7k
Linda D. Bosserman United States 24 1.8k 1.1× 1.1k 1.2× 513 1.0× 295 0.6× 527 1.1× 89 3.3k
Carlo Tondini Italy 28 1.2k 0.7× 567 0.6× 476 0.9× 363 0.7× 174 0.4× 104 2.3k
H.T. Mouridsen Denmark 22 1.4k 0.8× 1.3k 1.4× 362 0.7× 328 0.7× 206 0.4× 49 2.5k
Edward H. Romond United States 25 2.9k 1.7× 1.5k 1.6× 639 1.3× 519 1.1× 1.1k 2.3× 61 3.9k
Angela Moliterni Italy 21 2.1k 1.3× 1.7k 1.9× 396 0.8× 321 0.7× 305 0.7× 35 3.0k
G. Bonadonna Italy 25 1.9k 1.2× 1.3k 1.5× 585 1.2× 468 1.0× 195 0.4× 72 3.3k
David B. Duggan United States 22 1.4k 0.8× 770 0.8× 333 0.7× 321 0.7× 341 0.7× 41 2.4k
P. Fargeot France 30 1.7k 1.0× 899 1.0× 575 1.1× 355 0.7× 117 0.3× 87 2.7k
M. Namer France 29 2.4k 1.5× 1.4k 1.5× 982 2.0× 562 1.2× 264 0.6× 122 3.7k
B. Ojeda Spain 26 1.9k 1.1× 1.1k 1.2× 388 0.8× 380 0.8× 697 1.5× 57 2.8k

Countries citing papers authored by RD Gelber

Since Specialization
Citations

This map shows the geographic impact of RD Gelber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RD Gelber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RD Gelber more than expected).

Fields of papers citing papers by RD Gelber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RD Gelber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RD Gelber. The network helps show where RD Gelber may publish in the future.

Co-authorship network of co-authors of RD Gelber

This figure shows the co-authorship network connecting the top 25 collaborators of RD Gelber. A scholar is included among the top collaborators of RD Gelber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RD Gelber. RD Gelber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tutt, Andrew, Bella Kaufman, Judy E. Garber, et al.. (2017). OlympiA: A randomized phase III trial of olaparib as adjuvant therapy in patients with high-risk HER2-negative breast cancer (BC) and a germline BRCA1/2 mutation (gBRCAm). Annals of Oncology. 28. v67–v67. 16 indexed citations
3.
Jackisch, C, M. Piccart, RD Gelber, et al.. (2016). Abstract PD5-01: HERA trial: 10 years follow up of trastuzumab after adjuvant chemotherapy in HER2 positive early breast cancer – Final analysis. Cancer Research. 76(4_Supplement). PD5–1. 8 indexed citations
4.
5.
Regan, MM, U. Dafni, Dimitris Karlis, et al.. (2012). Abstract P5-18-02: Selective Crossover in Randomized Trials of Adjuvant Trastuzumab for Breast Cancer: Coping with Success. Cancer Research. 72(24_Supplement). P5–18.
6.
Viale, Giuseppe, MM Regan, Patrizia Dell’Orto, et al.. (2011). Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. Annals of Oncology. 22(10). 2201–2207. 65 indexed citations
7.
Mauriac, L., Aparna Keshaviah, Marc Debled, et al.. (2007). Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Annals of Oncology. 18(5). 859–867. 106 indexed citations
8.
9.
Colleoni, Marco, RD Gelber, Giuseppe Viale, et al.. (2003). Preoperative systemic treatment: prediction of responsiveness. The Breast. 12(6). 538–542. 29 indexed citations
10.
Gelber, RD, Monica Castiglione‐Gertsch, Alan S. Coates, & Aron Goldhirsch. (2003). Tailored treatment investigations for premenopausal women with endocrine responsive (ER+ and/or PgR+) breast cancer: The open questions. The Breast. 12. S43–S44. 5 indexed citations
11.
Aebi, Stefan, Shari Gelber, Monica Castiglione‐Gertsch, et al.. (2000). Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?. The Lancet. 355(9218). 1869–1874. 212 indexed citations
12.
Gelber, RD, et al.. (1998). Quality of Life Assessment in the Adjuvant Setting: Is It Relevant?. Recent results in cancer research. 152. 373–389. 12 indexed citations
13.
Castiglione‐Gertsch, Monica, Martin Tattersall, A Hacking, et al.. (1997). Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. European Journal of Cancer. 33(14). 2321–2325. 15 indexed citations
14.
Pestalozzi, Bernhard C., Harriet F. Peterson, RD Gelber, et al.. (1997). Prognostic importance of thymidylate synthase expression in early breast cancer.. Journal of Clinical Oncology. 15(5). 1923–1931. 107 indexed citations
15.
Glick, John H., RD Gelber, Aron Goldhirsch, & Hans-Jörg Senn. (1992). Meeting Highlights: Adjuvant Therapy for Primary Breast Cancer. JNCI Journal of the National Cancer Institute. 84(19). 1479–1479. 71 indexed citations
16.
Gusterson, B.A., RD Gelber, Aron Goldhirsch, et al.. (1992). Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.. Journal of Clinical Oncology. 10(7). 1049–1056. 698 indexed citations breakdown →
17.
Gerber, H., G. Locher, Aron Goldhirsch, et al.. (1990). c-erbB-2 protein expression in node negative breast cancer. Annals of Oncology. 1(4). 263–268. 31 indexed citations
18.
Castiglione, M., RD Gelber, & Aron Goldhirsch. (1990). Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group.. Journal of Clinical Oncology. 8(3). 519–526. 73 indexed citations
19.
Goldhirsch, Aron, Richard Greiner, E. Dreher, et al.. (1988). Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapy. Cancer. 62(1). 40–47. 36 indexed citations
20.
Weinstein, Howard J., Robert J. Mayer, DS Rosenthal, et al.. (1983). The Treatment of Acute Myelogenous Leukemia in Children and Adults: VAPA Update. Hämatologie und Bluttransfusion. 28. 41–45. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda D. Bosserman Breakdown of academic impact, for papers by Carlo Tondini Breakdown of academic impact, for papers by H.T. Mouridsen Breakdown of academic impact, for papers by Edward H. Romond Breakdown of academic impact, for papers by Angela Moliterni Breakdown of academic impact, for papers by G. Bonadonna Breakdown of academic impact, for papers by David B. Duggan Breakdown of academic impact, for papers by P. Fargeot Breakdown of academic impact, for papers by M. Namer Breakdown of academic impact, for papers by B. Ojeda
Rankless by CCL
2026